Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1918 1
1919 2
1920 1
1922 1
1923 1
1924 4
1925 2
1928 3
1929 3
1930 3
1931 1
1932 1
1933 10
1934 1
1935 4
1937 5
1938 2
1939 3
1941 3
1942 2
1943 1
1945 1
1946 6
1947 7
1948 4
1949 7
1950 9
1951 14
1952 11
1953 13
1954 14
1955 5
1956 12
1957 5
1958 9
1959 10
1960 23
1961 11
1962 10
1963 20
1964 15
1965 13
1966 15
1967 18
1968 13
1969 24
1970 23
1971 29
1972 22
1973 19
1974 30
1975 21
1976 23
1977 27
1978 29
1979 18
1980 29
1981 36
1982 23
1983 35
1984 36
1985 31
1986 35
1987 36
1988 27
1989 33
1990 31
1991 29
1992 46
1993 36
1994 43
1995 31
1996 28
1997 30
1998 30
1999 46
2000 35
2001 53
2002 35
2003 36
2004 36
2005 42
2006 66
2007 76
2008 72
2009 91
2010 98
2011 89
2012 108
2013 101
2014 102
2015 106
2016 122
2017 149
2018 124
2019 124
2020 140
2021 167
2022 148
2023 148
2024 64

Text availability

Article attribute

Article type

Publication date

Search Results

3,313 results

Results by year

Filters applied: . Clear all
Page 1
In Reply.
Pavlik EJ, Lasher A, Harris LE, Solomon AL, Harbin LM, Raby L, Dietrich CS, Kryscio RJ, van Nagell JR Jr. Pavlik EJ, et al. Among authors: harris le. Obstet Gynecol. 2024 May 1;143(5):e140-e142. doi: 10.1097/AOG.0000000000005559. Obstet Gynecol. 2024. PMID: 38636089 No abstract available.
Gentrification drives patterns of alpha and beta diversity in cities.
Fidino M, Sander HA, Lewis JS, Lehrer EW, Rivera K, Murray MH, Adams HC, Kase A, Flores A, Stankowich T, Schell CJ, Salsbury CM, Rohnke AT, Jordan MJ, Green AM, R Gramza A, Zellmer AJ, Williamson J, Surasinghe TD, Storm H, Sparks KL, Ryan TJ, Remine KR, Pendergast ME, Mullen K, Minier DE, Middaugh CR, Mertl AL, McClung MR, Long RA, Larson RN, Kohl MT, Harris LR, Hall CT, Haight JD, Drake D, Davidge AM, Cheek AO, Bloch CP, Biro EG, Anthonysamy WJB, Angstmann JL, Allen ML, Adalsteinsson SA, Short Gianotti AG, LaMontagne JM, Gelmi-Candusso TA, Magle SB. Fidino M, et al. Among authors: harris lr. Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2318596121. doi: 10.1073/pnas.2318596121. Epub 2024 Apr 15. Proc Natl Acad Sci U S A. 2024. PMID: 38621142
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
Gong J, Mita AC, Wei Z, Cheng HH, Mitchell EP, Wright JJ, Ivy SP, Wang V, Gray RC, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Alva AS, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT. Gong J, et al. Among authors: harris ln. JCO Precis Oncol. 2024 Apr;8:e2300406. doi: 10.1200/PO.23.00406. JCO Precis Oncol. 2024. PMID: 38603651 Clinical Trial.
3,313 results